En español
NIDA

Government Shutdown

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at USA.gov.

Research Abstracts

InWomen Working Group Publishes Journal Supplement

A new journal supplement focuses research attention on women who use substances, their diversity, the contextual factors affecting their lives, their needs, the treatment barriers they face, and next steps with regard to interventions and treatment.

Former DISCA Awardee and Colleagues Report Changes in Mexican Controls Reduced Methamphetamine Potency, Harm in United States

Former NIDA International Program Distinguished International Scientist Octavio Campollo, M.D., M.Sci., Ph.D., Mexico, and colleagues report in Drug and Alcohol Dependence that Mexico’s 2004 controls on ephedrine and pseudoephedrine changed the U.S. methamphetamine market. Restrictions on these precursor chemicals in Mexico resulted in widespread emergence of less potent methamphetamine and declines in prevalence and availability of the most potent type of the drug, which had dominated the U.S. market since the late 1980s. The authors found that U.S.